最新消息最新消息

12 月 7 日,华中科技大学附属协和医院成功实施全球首例新型细胞化肺动脉瓣置换术,为 13 岁先天性心脏病患儿玥玥提供了“补心”手术。该手术由该医院心血管外科主任团队完成,使用的是国际上首次应用的新型细胞化瓣膜材料。此次手术是国际上首次成功实施新型细胞化肺动脉瓣置换术,将为全球范围内的先天性心脏病患者提供新的治疗选择。

新闻翻译:
Title: Global First Case of New Cell-Based Pulmonic Valve Implantation Successfully Performed
Keywords: Global first case, new cell-based pulmonary valve, heart surgery

The news content reads:
On December 7th, the First Affiliated Hospital of Huazhong University of Science and Technology successfully performed the global first case of new cell-based pulmonary valve implantation for a 13-year-old patient with congenital heart disease, Yueyi. The surgery was carried out by the cardiology department of the hospital, using the new cell-based pulmonary valve material that has not been used before in the world. This surgery is the first time in the world that the new cell-based pulmonary valve implantation has been successfully performed, and it will provide a new treatment option for patients with congenital heart disease around the world.

【来源】http://www.chinanews.com/life/2023/12-08/10124526.shtml

Views: 1

发表回复

您的邮箱地址不会被公开。 必填项已用 * 标注